Diane L. Carlson

Medicine · Health Sciences

37h-index5.7kcitations93works0.02yr avg
OpenAlex↗ORCID↗Google Scholar↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Thyroid Cancer Diagnosis and Treatment(22), Head and Neck Cancer Studies(19), Head and Neck Surgical Oncology(14), Salivary Gland Tumors Diagnosis and Treatment(10), Oral and Maxillofacial Pathology(8)

Publications93 total

Supplementary legend from Genomic Alterations in Fatal Forms of Non-Anaplastic Thyroid Cancer: Identification of <i>MED12</i> and <i>RBM10</i> as Novel Thyroid Cancer Genes Associated with Tumor Virulence
2023Open Access
Table S1 from Genomic Alterations in Fatal Forms of Non-Anaplastic Thyroid Cancer: Identification of <i>MED12</i> and <i>RBM10</i> as Novel Thyroid Cancer Genes Associated with Tumor Virulence
2023Open Access
Data from Genomic Alterations in Fatal Forms of Non-Anaplastic Thyroid Cancer: Identification of <i>MED12</i> and <i>RBM10</i> as Novel Thyroid Cancer Genes Associated with Tumor Virulence
2023Open Access
Supplementary Table 2. from Genomic Alterations in Fatal Forms of Non-Anaplastic Thyroid Cancer: Identification of <i>MED12</i> and <i>RBM10</i> as Novel Thyroid Cancer Genes Associated with Tumor Virulence
2023Open Access
Supplementary Table 2. from Genomic Alterations in Fatal Forms of Non-Anaplastic Thyroid Cancer: Identification of <i>MED12</i> and <i>RBM10</i> as Novel Thyroid Cancer Genes Associated with Tumor Virulence
2023Open Access
Supplementary legend from Genomic Alterations in Fatal Forms of Non-Anaplastic Thyroid Cancer: Identification of <i>MED12</i> and <i>RBM10</i> as Novel Thyroid Cancer Genes Associated with Tumor Virulence
2023Open Access
Data from Genomic Alterations in Fatal Forms of Non-Anaplastic Thyroid Cancer: Identification of <i>MED12</i> and <i>RBM10</i> as Novel Thyroid Cancer Genes Associated with Tumor Virulence
2023Open Access
Figure S1 from Genomic Alterations in Fatal Forms of Non-Anaplastic Thyroid Cancer: Identification of <i>MED12</i> and <i>RBM10</i> as Novel Thyroid Cancer Genes Associated with Tumor Virulence
2023Open Access
Figure S2 from Genomic Alterations in Fatal Forms of Non-Anaplastic Thyroid Cancer: Identification of <i>MED12</i> and <i>RBM10</i> as Novel Thyroid Cancer Genes Associated with Tumor Virulence
2023Open Access
Figure S2 from Genomic Alterations in Fatal Forms of Non-Anaplastic Thyroid Cancer: Identification of <i>MED12</i> and <i>RBM10</i> as Novel Thyroid Cancer Genes Associated with Tumor Virulence
2023Open Access
Figure S3 from Genomic Alterations in Fatal Forms of Non-Anaplastic Thyroid Cancer: Identification of <i>MED12</i> and <i>RBM10</i> as Novel Thyroid Cancer Genes Associated with Tumor Virulence
2023Open Access
Figure S3 from Genomic Alterations in Fatal Forms of Non-Anaplastic Thyroid Cancer: Identification of <i>MED12</i> and <i>RBM10</i> as Novel Thyroid Cancer Genes Associated with Tumor Virulence
2023Open Access
Table S1 from Genomic Alterations in Fatal Forms of Non-Anaplastic Thyroid Cancer: Identification of <i>MED12</i> and <i>RBM10</i> as Novel Thyroid Cancer Genes Associated with Tumor Virulence
2023Open Access
Figure S1 from Genomic Alterations in Fatal Forms of Non-Anaplastic Thyroid Cancer: Identification of <i>MED12</i> and <i>RBM10</i> as Novel Thyroid Cancer Genes Associated with Tumor Virulence
2023Open Access
Data from Gene Expression Profiling Allows Distinction between Primary and Metastatic Squamous Cell Carcinomas in the Lung
2023Open Access
Supplementary Figure and Table from Gene Expression Profiling Allows Distinction between Primary and Metastatic Squamous Cell Carcinomas in the Lung
2023Open Access
Supplementary Figure and Table from Gene Expression Profiling Allows Distinction between Primary and Metastatic Squamous Cell Carcinomas in the Lung
2023Open Access
Data from Gene Expression Profiling Allows Distinction between Primary and Metastatic Squamous Cell Carcinomas in the Lung
2023Open Access
Clinical and Pathologic Features Associated With Invasive Breast Carcinoma With 2018 American Society of Clinical Oncology/College of American Pathologists In Situ Hybridization Group 2 Results (Human Epidermal Growth Factor Receptor 2 [ <i>HER2</i> ]/Chromosome 17 Centromere [CEP17] Ratio ≥2.0 and Average <i>HER2</i> Copy Number &amp;lt;4.0)
Archives of Pathology & Laboratory Medicine·2021· 2 citedOpen Access
Pseudofungi in an Immunocompromised Patient with Breast Cancer and COVID-19
Case Reports in Medicine·2020· 3 citedOpen Access
page 1 of 5Next →

Frequent Co-authors

Jatin P. Shah(21), Ronald Ghossein(15), Snehal G. Patel(13), Dennis H. Kraus(11), Ashok R. Shaha(10), Bhuvanesh Singh(9), Ian Ganly(9), Nancy Y. Lee(8), David G. Pfister(8), Hilda E. Stambuk(8), R. Michael Tuttle(7), Matthew G. Fury(6), Nora Katabi(5), Richard J. Wong(5), Cherry L. Estilo(4), Simon G. Talbot(4), Ronglai Shen(4), Heiko Schöder(3), Joseph M. Huryn(3), Ziv Gil(3)